Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy

Fig. 5

a Zn0.4Fe2.6O4 NPs, AFZD NPs, and AFZDA NPs inhibiting VEGF of HUVECs measured by Elisa kit Elisa at 24 h. b Western blot analysis for Ang2, b-FGF, and VEGFA expression in 0.1 mg/mL Zn0.4Fe2.6O4 NPs and AFZDA NPs treated HUVECs and β-actin was used as the internal reference. c The wound-healing assay indicating the migration ability of HUVECs using Vasculife-MV complete kit (0 h, 24 h, and 36 h after treatment with PBS or 0.1 mg/mL Zn0.4Fe2.6O4 NPs, scale bar = 200 µm. d The migration of HUVECs after treatment 36 h. All data are expressed as mean ± SD, n = 5 per group. P values were calculated using the two-paired Student’s t-test, treated groups vs. control group (*P < 0.05,**P < 0.01, ***P < 0.001)

Back to article page